« Back to Farmacia Journal 1/2016
ANTICANCER EFFECTS OF CO-ADMINISTRATION OF DAUNORUBICIN AND RESVERATROL IN MOLT-4, U266 B1 AND RAJI CELL LINES
HMOUD HASHEMZAEI1, SAEED PUDINE KARAMI1, AMIN DELARAMIFAR1, ALIREZA SHEIDARY1, KAVEH TABRIZIAN1,2, RAMIN REZAEE3, SHABNAM SHAHSAVAND3, ANDREEA LETIȚIA ARSENE4, ARISTIDIS MICHAEL TSATSAKIS5, SEYED MOHAMMAD TAGHDISI6*
1.Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran
2.Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran
3.Department of Physiology and Pharmacology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
4.Department of Biochemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6, Traian Vuia Street, sector 2, Bucharest, Romania
5.Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, Heraklion 71003, Greece
6.Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran